Which ASX ETFs hold Novo Nordisk A/S (NOVOB)?
As at Q3 2026, NOVOB is among the most widely held stocks across ASX-listed ETFs, appearing in approximately 22 ETFs. Its largest single position is approximately 2.12% in DRUG (Betashares Global Healthcare Currency Hedged ETF). General information only, not financial advice.
General information only, not financial advice. ETFLens does not hold an AFSL. Always read the relevant PDS and consider seeking advice from a licensed financial adviser.
All weights are approximate, drawn from each fund's published holdings as at Q3 2026, and change as funds rebalance.
| ETF | Fund | Category | Weight |
|---|---|---|---|
| DRUG | Betashares Global Healthcare Currency Hedged ETF | Thematic | approx. 2.12% |
| HLTH | VanEck Global Healthcare Leaders ETF | Thematic | approx. 1.77% |
| VEQ | Vanguard FTSE Europe Shares ETF | Global Broad Market | approx. 0.88% |
| INCM | Betashares S&P Global High Dividend Aristocrats ETF | Income & Dividends | approx. 0.77% |
| GARP | Global X S&P World ex Australia GARP ETF | Global Broad Market | approx. 0.71% |
| QUAL | VanEck MSCI International Quality ETF | Global Broad Market | approx. 0.52% |
| QHAL | VanEck MSCI International Quality (AUD Hedged) ETF | Global Broad Market | approx. 0.51% |
| EXUS | Betashares Global Shares EX US ETF | Global Broad Market | approx. 0.51% |
| ETHI | Betashares Global Sustainability Leaders ETF | ESG / Ethical | approx. 0.37% |
| HETH | Betashares Global Sustainability Leaders ETF - Currency Hedged | ESG / Ethical | approx. 0.37% |
| VEU | Vanguard All-World ex-US Shares Index ETF | Global Broad Market | approx. 0.34% |
| VIHY | Vanguard International Shares High Yield ETF | Income & Dividends | approx. 0.33% |
| VESG | Vanguard Ethically Conscious International Shares Index ETF | ESG / Ethical | approx. 0.19% |
| VGS | Vanguard MSCI Index International Shares ETF | Global Broad Market | approx. 0.16% |
| VGAD | Vanguard MSCI Index International Shares (Hedged) ETF | Global Broad Market | approx. 0.15% |
| WRLD | Betashares Managed Risk Global Share Fund (managed fund) | Global Broad Market | approx. 0.13% |
| HGBL | Betashares Global Shares Currency Hedged ETF | Global Broad Market | approx. 0.13% |
| BGBL | Betashares Global Shares ETF | Global Broad Market | approx. 0.13% |
| MQEG | Macquarie Core Global Equity Active ETF | Global Broad Market | approx. 0.07% |
| MQHG | Macquarie Core Global Equity (Hedged) Active ETF | Global Broad Market | approx. 0.07% |
| VCF | Vanguard International Credit Securities Index (Hedged) ETF | Bonds | approx. 0.03% |
| VBND | Vanguard Global Aggregate Bond Index (Hedged) ETF | Bonds | approx. 0.01% |
Want to see what any of these funds overlap with? Try the free ETF overlap checker, or browse the most widely held stocks.
Hold more than one of these? See your combined NOVOB exposure across all your ETFs with the Stock X-Ray.
NOVOB in ETFs: frequently asked questions
Which ASX ETFs hold NOVOB?
Novo Nordisk A/S (NOVOB) is held by approximately 22 ASX-listed ETFs, including DRUG, HLTH, VEQ, INCM, GARP. General information only.
Which ETF has the largest NOVOB weighting?
DRUG (Betashares Global Healthcare Currency Hedged ETF) has the largest NOVOB position at approximately 2.12% of the fund, as at Q3 2026. Past weightings are not a reliable indicator of future weightings.